Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Protective effect of a mixture of kefir-isolated lactic acid bacteria and yeasts in a hamster model of Clostridium difficile infection.

Bolla PA, Carasi P, Bolla Mde L, De Antoni GL, Serradell Mde L.

Anaerobe. 2013 Jun;21:28-33. doi: 10.1016/j.anaerobe.2013.03.010. Epub 2013 Mar 29.

PMID:
23542116
2.

Kefir-isolated Lactococcus lactis subsp. lactis inhibits the cytotoxic effect of Clostridium difficile in vitro.

Bolla PA, Carasi P, Serradell Mde L, De Antoni GL.

J Dairy Res. 2013 Feb;80(1):96-102. doi: 10.1017/S0022029912000623. Epub 2012 Dec 10.

PMID:
23217732
3.

Effect of freeze-drying on viability and in vitro probiotic properties of a mixture of lactic acid bacteria and yeasts isolated from kefir.

Bolla PA, Serradell Mde L, de Urraza PJ, De Antoni GL.

J Dairy Res. 2011 Feb;78(1):15-22. doi: 10.1017/S0022029910000610. Epub 2010 Sep 8.

PMID:
20822567
4.

The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.

Yang XQ, Zhao YG, Chen XQ, Jiang B, Sun DY.

BMC Gastroenterol. 2013 Jul 17;13:117. doi: 10.1186/1471-230X-13-117.

5.

Protective effect of bifidobacteria in an experimental model of Clostridium difficile associated colitis.

Trejo FM, De Antoni GL, Pérez PF.

J Dairy Res. 2013 Aug;80(3):263-9. doi: 10.1017/S0022029913000216. Epub 2013 Apr 23.

PMID:
23611644
6.

Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.

Anton PM, O'Brien M, Kokkotou E, Eisenstein B, Michaelis A, Rothstein D, Paraschos S, Kelly CP, Pothoulakis C.

Antimicrob Agents Chemother. 2004 Oct;48(10):3975-9.

7.
8.

Clostridium difficile typhlitis associated with cecal mucosal hyperplasia in Syrian hamsters.

Ryden EB, Lipman NS, Taylor NS, Rose R, Fox JG.

Lab Anim Sci. 1991 Dec;41(6):553-8.

PMID:
1667196
9.

Lactic acid bacteria and yeasts in kefir grains and kefir made from them.

Simova E, Beshkova D, Angelov A, Hristozova Ts, Frengova G, Spasov Z.

J Ind Microbiol Biotechnol. 2002 Jan;28(1):1-6.

PMID:
11938463
10.

Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.

Nagaro KJ, Phillips ST, Cheknis AK, Sambol SP, Zukowski WE, Johnson S, Gerding DN.

Antimicrob Agents Chemother. 2013 Nov;57(11):5266-70. doi: 10.1128/AAC.00580-13. Epub 2013 Aug 12.

11.

Investigation on culturable microflora in Tibetan kefir grains from different areas of China.

Gao J, Gu F, Abdella NH, Ruan H, He G.

J Food Sci. 2012 Aug;77(8):M425-33. doi: 10.1111/j.1750-3841.2012.02805.x.

PMID:
22860591
12.

Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins.

O'Brien JB, McCabe MS, Athié-Morales V, McDonald GS, Ní Eidhin DB, Kelleher DP.

FEMS Microbiol Lett. 2005 May 15;246(2):199-205.

14.

Surface proteins from Lactobacillus kefir antagonize in vitro cytotoxic effect of Clostridium difficile toxins.

Carasi P, Trejo FM, Pérez PF, De Antoni GL, Serradell Mde L.

Anaerobe. 2012 Feb;18(1):135-42. doi: 10.1016/j.anaerobe.2011.11.002. Epub 2011 Nov 22.

PMID:
22126976
15.

Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.

Anosova NG, Brown AM, Li L, Liu N, Cole LE, Zhang J, Mehta H, Kleanthous H.

J Med Microbiol. 2013 Sep;62(Pt 9):1394-404. doi: 10.1099/jmm.0.056796-0. Epub 2013 Mar 21.

PMID:
23518659
16.

Metabolic activity and symbiotic interactions of lactic acid bacteria and yeasts isolated from water kefir.

Stadie J, Gulitz A, Ehrmann MA, Vogel RF.

Food Microbiol. 2013 Sep;35(2):92-8. doi: 10.1016/j.fm.2013.03.009. Epub 2013 Apr 11.

PMID:
23664259
17.

Infection of hamsters with epidemiologically important strains of Clostridium difficile.

Sambol SP, Tang JK, Merrigan MM, Johnson S, Gerding DN.

J Infect Dis. 2001 Jun 15;183(12):1760-6. Epub 2001 May 11.

PMID:
11372028
18.

In vivo and in vitro studies of Clostridium difficile-induced disease in hamsters fed an atherogenic, high-fat diet.

Blankenship-Paris TL, Chang J, Dalldorf FG, Gilligan PH.

Lab Anim Sci. 1995 Feb;45(1):47-53.

PMID:
7752614
20.

New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration.

Merrigan MM, Sambol SP, Johnson S, Gerding DN.

Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S46-50. doi: 10.1016/S0924-8579(09)70017-2.

PMID:
19303570

Supplemental Content

Support Center